Medicaid Rx Price Data Could Be Used For Medicare Payments - HHS IG
Executive Summary
The "Average Manufacturer Price" used as the basis for rebate calculations in Medicaid is the best alternative to AWP for reforming the Medicare prescription drug reimbursement methodology, HHS Deputy Inspector General George Grob suggested during a Sept. 21 hearing.
You may also be interested in...
AWP Class Action Proceeds; Congress’ Inaction Is No Defense, Judge Rules
Pharmaceutical manufacturers cannot use the lack of Congressional action on AWP reform as a defense in class action suits filed over the issue, Boston federal court Judge Patti Saris ruled
AWP Class Action Proceeds; Congress’ Inaction Is No Defense, Judge Rules
Pharmaceutical manufacturers cannot use the lack of Congressional action on AWP reform as a defense in class action suits filed over the issue, Boston federal court Judge Patti Saris ruled
Medicare AWP Reform: “Get The Doctors Out Of The Pharmacy Business”
The problems with Medicare's AWP payment system for oncology products suggests that the federal government needs to "get the doctors out of the pharmacy business," Aetna CEO John Rowe declared during a March 21 Medicare Payments Advisory Commission meeting